Vaccine Technology
🇺🇸 FDAFDA news and analysis for pharmaceutical BD, investment, and market access
Unlock global vaccine technology insights for pharma BD, investment, and R&D. Stay ahead in infectious disease and therapeutic innovation.
Showing 1–3 of 3 articles
Quick answer
NovaPharmaNews Vaccine Technology hub for FDA covers 3 published articles — news and analysis for pharma BD, investors, and market access teams. Browse related topics below or explore companies, pipeline, and events linked from each story.
BioNTech doses first patient in Phase 1 pancreatic cancer mRNA vaccine trial
FDA Approval mRNA Vaccine RSV: Market Impact & Future Outlook
AACR 2026: Myocarditis Risk, KRAS Inhibitors, mRNA Advances
Frequently asked questions
How often is this topic updated?
New articles are published continuously as regulatory, clinical, and commercial signals break. Use the content-type filters for latest news vs in-depth analysis.
Where does this coverage come from?
Editorial intelligence combines FDA openFDA, ClinicalTrials.gov, SEC EDGAR, congress calendars, and analyst reporting. See our data sources policy for attribution.